Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants
Phase 1
Completed
- Conditions
- Out-Of-Hospital Cardiac ArrestHealthy
- Interventions
- First Posted Date
- 2021-09-30
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Robert Silbergleit
- Target Recruit Count
- 24
- Registration Number
- NCT05062785
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications
Phase 3
Completed
- Conditions
- Status Epilepticus
- Interventions
- Drug: Intramuscular route of active treatmentDrug: Intravenous route of active treatment
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2016-06-17
- Lead Sponsor
- Robert Silbergleit
- Target Recruit Count
- 1023
- Registration Number
- NCT00809146
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸Stanford University, Palo Alto, California, United States
🇺🇸University of California-San Francisco, San Francisco, California, United States
News
No news found